The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,878.00
Bid: 10,886.00
Ask: 10,888.00
Change: -146.00 (-1.32%)
Spread: 2.00 (0.018%)
Open: 10,882.00
High: 10,966.00
Low: 10,822.00
Prev. Close: 11,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

As UK prepares to roll out COVID-19 vaccines, scepticism remains

Mon, 07th Dec 2020 06:00

* Britain to begin vaccine programme this week

* Governments seek to reassure over safety, efficacy

* Many swayed by misinformation, conspiracy theories

By Natalie Thomas

LONDON, Dec 7 (Reuters) - A sizeable minority of people
believe conspiracy theories about the coronavirus and COVID-19
vaccines, some experts have warned, just as countries prepare to
launch mass inoculations to get the pandemic under control.

Britain begins its vaccine programme this week and others
are likely to follow soon, so governments are seeking to
reassure people of vaccines' safety and efficacy in order to get
a critical mass to take them.

In the United States, President-elect Joe Biden said he
would have a coronavirus vaccine publicly to demonstrate its
safety, and referred to people losing faith in the vaccine's
ability to work.

"What we're finding is, in the wake of the pandemic, that
conspiracy beliefs may have gone mainstream, that they're no
longer confined to the fringes," Daniel Freeman, Professor of
Clinical Psychology at Oxford University, told Reuters.

"Around a quarter (of Britain's population) are entertaining
such thoughts. Another quarter are consistently thinking in
terms of conspiracy beliefs, and around one in 10 people seem to
have a very high rate of endorsement of conspiracy beliefs."

The World Health Organization estimates a 65-70% vaccine
coverage rate as necessary to reach population immunity through
vaccination, though the idea of herd immunity assumes a vaccine
prevents transmission, not just the disease itself.

A survey in Britain last month showed that almost two-thirds
of people would get vaccinated for the disease. But many have
expressed unease at the speed at which companies have developed
the drugs to tackle it, and about possible side effects.

Based on published vaccines trial data generated so far this
year by Moderna, the BioNTech-Pfizer partnership and
AstraZeneca, side effects have not been serious or long lasting.

Some also believe unfounded claims spread over the Internet,
including that the pandemic was fabricated by governments to
control people or that Microsoft co-founder Bill Gates wanted to
use vaccines to insert trackable microchips into people.

At a recent protest in central London, hundreds of people
shouted slogans against COVID-19 lockdown measures and
vaccinations.

One demonstrator, Michelle, called the pandemic a "hoax".
"It's a cover-up while they reset the whole economy," she
shouted.

'IT MAKES YOU PARANOID'

Leila Hay, a university student in the northern English city
of Hull, said she ended up believing some of what she read
online about vaccines and the pandemic, even though she now says
it has no basis in truth.

"I was looking at a lot of groups, and they were just there
for anyone to go into, they were very public and had a lot of
followers," the 19-year-old recalled.

Some of the theories she once espoused came via QAnon, a
platform that has become a "big tent" conspiracy theory
encompassing misinformation about topics ranging from alien
landings to vaccine safety.

Followers of QAnon say a so-called Great Awakening is coming
to bring salvation.

"It makes you really paranoid because you think everyone's
against you, like the system's against you and the government's
against you," said Hay.

"I was constantly preparing for the absolute worst scenario,
like a new world order was going to happen."

Tom Phillips, editor at fact-checking charity Full Fact,
said rumours and false information during pandemics have been
around for centuries.

"What technology has done is it's enabled them to spread far
more quickly and far more internationally in a way that is
fairly unprecedented," he said.

"Rumour can begin in Italy one day and it can be across
multiple continents a few days later, as we have seen happen
several times."

Oxford University's Freeman said he had been surprised by
how many people were entertaining unfounded ideas.

"I think conspiracy thinking can be pernicious. And, you
know, it's a time we all need to come together and conspiracy
beliefs typically divide."
(Reporting by Natalie Thomas; Writing by Mike Collett-White;
Editing by Janet Lawrence)

More News
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.